JP2007501288A5 - - Google Patents

Download PDF

Info

Publication number
JP2007501288A5
JP2007501288A5 JP2006536536A JP2006536536A JP2007501288A5 JP 2007501288 A5 JP2007501288 A5 JP 2007501288A5 JP 2006536536 A JP2006536536 A JP 2006536536A JP 2006536536 A JP2006536536 A JP 2006536536A JP 2007501288 A5 JP2007501288 A5 JP 2007501288A5
Authority
JP
Japan
Prior art keywords
amino
salt
dione
phenoxy
methoxycarbonylethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006536536A
Other languages
English (en)
Japanese (ja)
Other versions
JP4833072B2 (ja
JP2007501288A (ja
Filing date
Publication date
Priority claimed from US10/356,113 external-priority patent/US6794401B2/en
Application filed filed Critical
Publication of JP2007501288A publication Critical patent/JP2007501288A/ja
Publication of JP2007501288A5 publication Critical patent/JP2007501288A5/ja
Application granted granted Critical
Publication of JP4833072B2 publication Critical patent/JP4833072B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006536536A 2003-01-17 2004-01-13 アミノ酸フェノキシエーテル Expired - Fee Related JP4833072B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US44077203P 2003-01-17 2003-01-17
US60/440,772 2003-01-17
US10/356,113 US6794401B2 (en) 2003-01-17 2003-01-31 Amino acid phenoxy ethers
US10/356,113 2003-01-31
PCT/US2004/000790 WO2004066964A2 (en) 2003-01-17 2004-01-13 Amino acid phenoxy ethers

Publications (3)

Publication Number Publication Date
JP2007501288A JP2007501288A (ja) 2007-01-25
JP2007501288A5 true JP2007501288A5 (enExample) 2008-12-11
JP4833072B2 JP4833072B2 (ja) 2011-12-07

Family

ID=32716922

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006536536A Expired - Fee Related JP4833072B2 (ja) 2003-01-17 2004-01-13 アミノ酸フェノキシエーテル

Country Status (20)

Country Link
US (2) US6794401B2 (enExample)
EP (1) EP1583529B9 (enExample)
JP (1) JP4833072B2 (enExample)
KR (1) KR101085315B1 (enExample)
AT (1) ATE532510T1 (enExample)
AU (1) AU2004207449A1 (enExample)
BR (1) BRPI0406772B1 (enExample)
CA (1) CA2513496C (enExample)
CY (1) CY1112673T1 (enExample)
DK (1) DK1583529T3 (enExample)
EA (1) EA200501078A1 (enExample)
ES (1) ES2374724T3 (enExample)
MA (1) MA27658A1 (enExample)
MX (1) MXPA05007684A (enExample)
NO (1) NO330984B1 (enExample)
NZ (1) NZ541328A (enExample)
PT (1) PT1583529E (enExample)
SI (1) SI1583529T1 (enExample)
TW (1) TWI325420B (enExample)
WO (1) WO2004066964A2 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7781464B2 (en) * 2003-01-17 2010-08-24 Bexel Pharmaceuticals, Inc. Heterocyclic diphenyl ethers
US7521465B2 (en) * 2003-01-17 2009-04-21 Bexel Pharmaceuticals, Inc. Diphenyl ether derivatives
US7087576B2 (en) * 2003-10-07 2006-08-08 Bexel Pharmaceuticals, Inc. Dipeptide phenyl ethers
US7592486B2 (en) * 2004-09-16 2009-09-22 Board Of Regents Of The University Of Nebraska Anhydrous fluoride salts and reagents and methods for their production
JP2008533122A (ja) * 2005-03-18 2008-08-21 オーキッド ケミカルズ アンド ファーマシューティカルズ リミテッド 新規なチロシン誘導体
WO2007029062A2 (en) * 2005-07-29 2007-03-15 Orchid Research Laboratories Limited Novel pyridine derivatives
US7989480B2 (en) 2006-08-04 2011-08-02 Decode Genetics Ehf Aryl amino acid derivatives as inhibitors for treating inflammation
KR20100037047A (ko) * 2007-06-26 2010-04-08 렉시컨 파마슈티컬스 인코퍼레이티드 세로토닌-매개 질환 및 장애의 치료 방법
AU2008275179B2 (en) 2007-07-11 2013-09-12 Lexicon Pharmaceuticals, Inc. Methods and compositions for treating pulmonary hypertension and related diseases and disorders
WO2009030968A1 (en) * 2007-09-05 2009-03-12 Orchid Research Laboratories Limited Mao a inhibitors with a diphenyl ether-substructure.
ATE536347T1 (de) 2008-05-20 2011-12-15 Merck Sharp & Dohme Effiziente herstellung heterologer proteine unter verwendung von mannosyltransferaseinhibitoren
US20140187594A1 (en) 2010-07-28 2014-07-03 Orchid Chemicals And Pharmaceuticals Ltd Diphenyl ether compounds for the treatment of liver, lung disorders, diabetic complications and cardiovascular diseases
WO2012153775A1 (ja) 2011-05-10 2012-11-15 国立大学法人神戸大学 Ras機能阻害作用を有するチオキソチアゾリジン誘導体

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020049240A1 (en) * 1994-12-19 2002-04-25 Beecham Group P.1.C. Novel compounds
US5166137A (en) * 1991-03-27 1992-11-24 Nobipols Forskningsstiftelse Guluronic acid polymers and use of same for inhibition of cytokine production
US5441971A (en) * 1991-04-11 1995-08-15 The Upjohn Company Thiazolidinedione derivatives, production and use thereof
ATE185564T1 (de) * 1992-08-31 1999-10-15 Sankyo Co Oxazolidin-derivate mit antidiabetika und anti- fettleibigkeit-eigenschaften, ihre herstellung und therapeutische verwendung
TW268952B (enExample) * 1993-02-26 1996-01-21 Takeda Pharm Industry Co Ltd
CA2171827C (en) * 1993-09-15 2004-06-29 Jerrold Olefsky Use of thiazolidinediones to prevent or delay onset of niddm
US5527546A (en) * 1994-08-10 1996-06-18 Bayer Corporation Human interleukin 6 inhibitor
DE4432101A1 (de) * 1994-09-09 1996-03-14 Hoechst Ag Aminosäure-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
WO1996035782A1 (en) * 1995-05-11 1996-11-14 Applied Research Systems Il-6 activity inhibitor
IL118474A (en) * 1995-06-01 2001-08-08 Sankyo Co Benzimideol derivatives and pharmaceutical preparations containing them
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
TW577875B (en) * 1997-01-31 2004-03-01 Shionogi & Co Pyrrolidine derivatives with inhibitory activity for phospholipase A2
JPH11124331A (ja) * 1997-08-21 1999-05-11 Takeda Chem Ind Ltd 抗炎症剤
US6331633B1 (en) * 1998-05-08 2001-12-18 Calyx Therapeutics Inc. Heterocyclic analogs of diphenylethylene compounds
US6699896B1 (en) * 1998-05-12 2004-03-02 Wyeth Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
HUP0103082A3 (en) * 1998-06-05 2002-12-28 Astrazeneca Ab Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
KR100613175B1 (ko) * 1998-08-27 2006-08-17 오노 야꾸힝 고교 가부시키가이샤 카르복실산 유도체 및 그 유도체를 유효 성분으로서함유하는 약제
PT1177187E (pt) 1999-04-28 2007-09-03 Sanofi Aventis Deutschland Derivados ácidos de di-arilo como ligados do receptor ppar.
TWI284533B (en) * 1999-05-24 2007-08-01 Sankyo Co Pharmaceutical composition for treating hyperglycemia, impaired glucose tolerance, diabetes complications and for improving insulin resistant
WO2001002377A1 (en) 1999-07-01 2001-01-11 Geron Corporation Telomerase inhibitors and methods of their use
AU778720B2 (en) * 1999-08-23 2004-12-16 Kyorin Pharmaceutical Co. Ltd. Substituted benzylthiazolidine-2,4-dione derivatives
US6515003B1 (en) * 1999-08-31 2003-02-04 Maxia Pharmaceuticals, Inc. Heterocyclic derivatives for the treatment of diabetes and other diseases
JP2001199888A (ja) * 2000-01-24 2001-07-24 Fujimoto Brothers:Kk 糖尿病治療剤
JP2001294537A (ja) * 2000-02-10 2001-10-23 Takeda Chem Ind Ltd 併用医薬
DE60115132T2 (de) 2000-04-21 2006-07-06 Pfizer Products Inc., Groton Thyroid-Rezeptorliganden
US6680387B2 (en) * 2000-04-24 2004-01-20 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis

Similar Documents

Publication Publication Date Title
JP2007501288A5 (enExample)
US6498174B1 (en) Substituted oxazoles and thiazoles derivatives as hPPARγ and hPPARα activators
DK2038265T3 (en) Inhibitors of human protein tyrosine phosphatase and methods of use
CN1069901C (zh) N-苄基二氧代噻唑烷基苯甲酰胺衍生物及其制造方法
AU773505B2 (en) Arylthiazolidinedione and aryloxazolidinedione derivatives
CN1529698A (zh) 用于治疗心血管及有关疾病的噻唑或噁唑衍生物
JP2010519181A5 (enExample)
JP2005524665A (ja) Ppar活性を調節するチアゾールおよびオキサゾール誘導体
CN1703407A (zh) 脂肪酸酰胺水解酶抑制剂
JP3373198B2 (ja) アリールチアゾリジンジオン誘導体
CN1382129A (zh) 取代的苄基噻唑烷-2,4-二酮衍生物
CN1145027A (zh) 胰岛素敏化物治疗肾病的应用
CN100439345C (zh) 作为用于治疗 2型糠尿病和动脉硬化症的ppar调节剂的 3 - ( 2 -苯基 -噁唑-4-基甲氧基)环己基甲氧基乙酸衍生物和相关化合物
US7220864B2 (en) Dihydronaphthalene derivative compounds and agent comprising the derivative as active ingredient
AU2001258841B2 (en) Heterocyclic compounds
JP2008530242A5 (enExample)
JP2013507397A5 (enExample)
TW200418792A (en) Amino acid phenoxy ethers
WO2010082212A2 (en) N-biphenylacyl thiazolidine-2,4-dione derivatives, their synthesis and uses
Ortiz et al. Synthetic thiazolidinediones: potential antidiabetic compounds
RU2006102866A (ru) Тиазолзамещенные индолилпроизводные и их применение в качестве модуляторов ppar
EP2226321A3 (en) Process for producing thiazolidinediones and intermediates thereof
RU2005141516A (ru) Производные анилина
JP3884736B2 (ja) ハロゲノベンジルアミノプロピオン酸誘導体
ZA200204241B (en) Substituted oxazoles and thiazoles derivatives as HPPAR Alpha Activators.